How long does it take to stop taking Ixazomib (Enleri) and suggestions for stopping it?

Ixazomib (Ixazomib) is an oral proteasome inhibitor mainly used in the maintenance treatment or combination chemotherapy regimen of multiple myeloma. In clinical applications, the timing of drug discontinuation is usually determined by the patient's therapeutic response, tolerance, and the specific goals of the treatment plan. Generally speaking, if a patient achieves stable efficacy or complete remission after a period of continuous treatment and develops obvious adverse reactions, the doctor may evaluate whether to consider temporarily discontinuing the drug or adjusting the dosage.

Before discontinuing medication, the patient's condition and medication history need to be considered comprehensively. During treatment, patients should regularly monitor hematology, kidney and liver function, and myeloma indicators, such as Mprotein, free light chains or bone marrow images, etc., in order to evaluate whether the condition is stable. When the efficacy is stable and there is no sign of progression, doctors may recommend gradually discontinuing the drug after a certain period or entering an observation phase to reduce the risk of drug-related adverse reactions.

During discontinuation, attention should be paid to the risk of potential rebound or disease recurrence. Patients still need to regularly review hematological indicators and imaging examinations after stopping the drug in order to detect signs of disease activity early. If recurrence or disease progression occurs, ixazomib can be restarted or the treatment plan can be adjusted under the guidance of a doctor. At the same time, physical reactions during drug withdrawal should be recorded, including fatigue, blood cell changes, and kidney and liver function indicators, so that doctors can evaluate safety.

In addition, patients can maintain their health through lifestyle management and supportive treatment after discontinuation of medication. Ensuring a balanced diet, moderate exercise, and good sleep can help enhance immune function and overall tolerance. Psychological support is equally important. Patients should maintain communication with the medical team to understand the disease monitoring requirements and precautions after discontinuation of medication, so as to ensure the efficacy while minimizing the potential risks caused by discontinuation of medication.

Reference materials:https://www.drugs.com/